CD8A and neoplasm: These findings indicate that immunization with DTT-EG vaccines in the four experimental groups elicited activation of specific CD8+ T cells in mice, which subsequently infiltrated tumor tissues as effector CD8+ T cells and contributed to tumor lysis.